← Browse by Condition
Medical Condition
idiopathic inflammatory myopathies
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1, Phase 2
NCT06361745
Recruiting
Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
Enrollment
10 pts
Location
China
Sponsor
PersonGen BioTherapeutics (Suz...
NCT06665256 Phase 2
Recruiting
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
Enrollment
123 pts
Location
United States, Franc...
Sponsor
Novartis Pharmaceuticals
NCT07022197 Phase 1, Phase 2
Recruiting
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Enrollment
27 pts
Location
China
Sponsor
Tianjin Medical University Gen...